Concepedia

Marcus Ewing

ME

Statistics

Publications

5

Citations

164

H-Index

5

Active since

2003

Affiliations

Pfizer (United States)(Current)

Marcus Ewing is an author at Pfizer (United States) specializing in medicinal chemistry, synthetic medicinal chemistry, and drug discovery.

Publications per year

2003–2012

5

Publications

5

Deprotection of a primary Boc group under basic conditions

Norma J. Tom, Wendy M. Simon, Heather N. Frost et al. · Tetrahedron Letters · 2003 · 60 citations

, , +6

Streamlined Processes for the Synthesis of a Farnesyl Transferase Inhibitor Drug Candidate

Brian M. Andresen, Michel Couturier, Brian J. Cronin et al. · Organic Process Research & Development · 2004 · 39 citations

, , +12

Commercialization and Late-Stage Development of a Semisynthetic Antifungal API: Anidulafungin/<scp>d</scp>-Fructose (Eraxis)

Timothy Norris, John VanAlsten, Stephen E. Hubbs et al. · Organic Process Research & Development · 2008 · 27 citations

, , +17

Development of a Practical and Convergent Process for the Preparation of Sulopenem

Steven J. Brenek, Stéphane Caron, Esmort Chisowa et al. · Organic Process Research & Development · 2012 · 24 citations

, , +10

Synthesis of an H<sub>3</sub> Antagonist via Sequential One-Pot Additions of a Magnesium Ate Complex and an Amine to a 1,4-Ketoester followed by Carbonyl-Directed Fluoride Addition

Joel M. Hawkins, Pascal Dubé, Mark T. Maloney et al. · Organic Process Research & Development · 2012 · 14 citations

, , +8

1–5 of 5